Announced Thu, 6 Aug · 20:43 IST
Vijaya Diagnostic Q1 FY27 PAT jumps 36% YoY to Rs 53.1 cr on revenue up 23%
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults RestatedEmphasis Of MatterResults View source PDFExplain this filing
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.7%1-day move
₹1346.00
prior close
₹1384.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.5+1.0+0.9+1.4+3.7+6.8+13.1+9.9+9.0+10.8————
Up moveDown movePending
AI summary
Consolidated revenue rose 23% YoY to Rs 230.98 cr (from Rs 188.05 cr). PAT grew 38% YoY to Rs 53.10 cr (from Rs 38.59 cr). Standalone revenue at Rs 218.54 cr, up 23% YoY with PAT at Rs 53.15 cr, up 36%. Consolidated EPS at Rs 5.16 vs Rs 3.76 YoY. Board recommends Rs 2/share (200%) dividend for FY26. 1.79 lakh ESOPs granted. Comparatives restated for Medinova slump sale acquisition. Auditor issued unmodified review report.
Likely market impact
Strong topline and bottomline growth with margin expansion. Restated comparatives and 200% dividend proposal are positives for shareholders.